Promoting mechanisms of vascular health: circulating progenitor cells, angiogenesis, and reverse cholesterol transport.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of the American College of Cardiology

• Publication date

  2009-06-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jacc.2009.02.057PMID 19539140
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes.

  2010cited by this paper
• Inhibited atherosclerotic plaque formation by local administration of magnetically labeled endothelial progenitor cells (EPCs) in a rabbit model.

  2009cited by this paper
• Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid.

  2009cited by this paper
• Correction of HDL Dysfunction in Individuals With Diabetes and the Haptoglobin 2-2 Genotype

  2008cited by this paper
• Dual Therapy With Statins and Antioxidants Is Superior to Statins Alone in Decreasing the Risk of Cardiovascular Disease in a Subgroup of Middle-Aged Individuals With Both Diabetes Mellitus and the Haptoglobin 2-2 Genotype

  2008cited by this paper
• Review: Endothelial progenitor cells: markers of vascular reparative capacity

  2008cited by this paper
• Allograft Vasculopathy Versus Atherosclerosis Antibody and Complement in Transplant Vasculopathy Interferon- Axis in Graft Arteriosclerosis Vascular Remodeling in Transplant Vasculopathy Stem Cells and Transplant Arteriosclerosis Chemokines and Transplant Vasculopathy

  2008cited by this paper
• Mechanism of action of niacin.

  2008cited by this paper
• High-density lipoprotein exerts vasculoprotection via endothelial progenitor cells

  2008cited by this paper
• Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-I Milano (ETC-216) administration: magnetic resonance imaging study in an experimental model of atherosclerosis.

  2008cited by this paper
• Effects of exercise training upon endothelial function in patients with cardiovascular disease.

  2008cited by this paper
• Inflammatory angiogenesis in atherogenesis—a double-edged sword

  2008cited by this paper
• Haptoglobin genotype is a major determinant of the amount of iron in the human atherosclerotic plaque.

  2008cited by this paper
• Vascular repair by endothelial progenitor cells.

  2008cited by this paper
• Serial in vivo positive contrast MRI of iron oxide‐labeled embryonic stem cell‐derived cardiac precursor cells in a mouse model of myocardial infarction

  2008cited by this paper
• Nicotinic acid, alone and in combinations, for reduction of cardiovascular risk.

  2008cited by this paper
• Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population

  2008cited by this paper
• Evidence for genetic regulation of endothelial progenitor cells and their role as biological markers of atherosclerotic susceptibility.

  2008cited by this paper
• Circulating progenitor cells in stable coronary heart disease and acute coronary syndromes: relevant reparatory mechanism?

  2007cited by this paper
• Off-target properties of pharmacotherapy and the importance of mechanistic investigations in early clinical phase drug development

  2007cited by this paper
• Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment.

  2007cited by this paper
• Statins and the endothelium.

  2007cited by this paper
• The year in atherothrombosis.

  2007cited by this paper
• Two types of circulating endothelial progenitor cells in patients receiving long term therapy by HMG-CoA reductase inhibitors.

  2007cited by this paper
• Losartan Improves the Impaired Function of Endothelial Progenitor Cells in Hypertension via an Antioxidant Effect

  2007cited by this paper
• The Peroxisome Proliferator–Activated Receptor-γ Agonist Pioglitazone Increases Number and Function of Endothelial Progenitor Cells in Patients With Coronary Artery Disease and Normal Glucose Tolerance

  2007cited by this paper
• Downregulation of the Hemoglobin Scavenger Receptor in Individuals With Diabetes and the Hp 2-2 Genotype: Implications for the Response to Intraplaque Hemorrhage and Plaque Vulnerability

  2007influential reference
• Antiangiogenic therapy for normalization of atherosclerotic plaque vasculature: a potential strategy for plaque stabilization

  2007cited by this paper
• Low Priority of Cardiovascular and Chronic Diseases on the Global Health Agenda: A Cause for Concern

  2007cited by this paper
• Elimination of neoangiogenesis for plaque stabilization: is there a role for local drug therapy?

  2007cited by this paper
• Mechanisms of Disease: HDL metabolism as a target for novel therapies

  2007cited by this paper
• Effect of torcetrapib on the progression of coronary atherosclerosis.

  2007cited by this paper
• The Renin-Angiotensin System: A Potential Modulator of Endothelial Progenitor Cells

  2007cited by this paper
• Endothelial progenitor cells

  2007cited by this paper
• Choking off plaque neovascularity: a promising atheroprotective strategy or a double-edged sword?

  2007cited by this paper
• Ranibizumab for neovascular age-related macular degeneration.

  2007cited by this paper
• Haptoglobin Genotype Is a Determinant of Iron, Lipid Peroxidation, and Macrophage Accumulation in the Atherosclerotic Plaque

  2007cited by this paper
• Endothelial progenitor cells: a promising therapeutic alternative for cardiovascular disease.

  2007cited by this paper
• Vitamin E Supplementation Reduces Cardiovascular Events in a Subgroup of Middle-Aged Individuals With Both Type 2 Diabetes Mellitus and the Haptoglobin 2-2 Genotype: A Prospective Double-Blinded Clinical Trial

  2007cited by this paper
• Atherosclerosis in the back yard.

  2007cited by this paper
• Ranibizumab in neovascular age-related macular degeneration

  2006cited by this paper
• Neovascularization in human atherosclerosis.

  2006cited by this paper
• Neovascularization in Human Atherosclerosis

  2006cited by this paper
• Inflammation and cardiovascular disease mechanisms.

  2006cited by this paper
• ATP depletion in macrophages in the core of advanced rabbit atherosclerotic plaques in vivo.

  2006cited by this paper
• Number and Function of Endothelial Progenitor Cells as a Marker of Severity for Diabetic Vasculopathy

  2006cited by this paper
• The effects of HMG-CoA reductase inhibitor on vascular progenitor cells.

  2006cited by this paper
• Intraplaque hemorrhage.

  2006cited by this paper
• Molecular regulation of HDL metabolism and function: implications for novel therapies.

  2006cited by this paper
• The failure of torcetrapib: was it the molecule or the mechanism?

  2006cited by this paper
• Pathogenesis of atherosclerosis.

  2006cited by this paper
• Erythropoietin-Mobilized Endothelial Progenitors Enhance Reendothelialization via Akt–Endothelial Nitric Oxide Synthase Activation and Prevent Neointimal Hyperplasia

  2006cited by this paper
• Granulocyte colony-stimulating factor (G-CSF) accelerates reendothelialization and reduces neointimal formation after vascular injury in mice.

  2006cited by this paper
• Clinical and therapeutical implications of EPC biology in atherosclerosis

  2006cited by this paper
• Stem Cells and Their Niches

  2006cited by this paper
• Circulating endothelial progenitor cells predict coronary artery disease severity.

  2006cited by this paper
• HDL as a target in the treatment of atherosclerotic cardiovascular disease

  2005cited by this paper
• Atherosclerosis 2005: recent discoveries and novel hypotheses.

  2005cited by this paper
• Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture.

  2005cited by this paper
• Atherothrombosis and high-risk plaque: part I: evolving concepts.

  2005cited by this paper
• Impaired progenitor cell activity in age-related endothelial dysfunction.

  2005cited by this paper
• HDL as a target in the treatment of atherosclerotic cardiovascular disease

  2005cited by this paper
• Circulating endothelial progenitor cells and cardiovascular outcomes.

  2005cited by this paper
• Inflammation, atherosclerosis, and coronary artery disease.

  2005cited by this paper
• Angiogenesis: where do we stand now?

  2005cited by this paper
• Haptoglobin Genotype– and Diabetes-Dependent Differences in Iron-Mediated Oxidative Stress In Vitro and In Vivo

  2005cited by this paper
• Oral Small Peptides Render HDL Antiinflammatory in Mice and Monkeys and Reduce Atherosclerosis in ApoE Null Mice

  2005cited by this paper
• The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes.

  2004cited by this paper
• High-density lipoproteins: a new potential therapeutic target for the prevention of cardiovascular disease.

  2004cited by this paper
• Haptoglobin: a major susceptibility gene for diabetic cardiovascular disease.

  2004cited by this paper
• Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes.

  2004cited by this paper
• Plaque Neovascularization Is Increased in Ruptured Atherosclerotic Lesions of Human Aorta: Implications for Plaque Vulnerability

  2004cited by this paper
• New aspects in the pathogenesis of diabetic atherothrombosis.

  2004cited by this paper
• Oral D-4F Causes Formation of Pre-βHigh-Density Lipoprotein and Improves High-Density Lipoprotein–Mediated Cholesterol Efflux and Reverse Cholesterol Transport From Macrophages in Apolipoprotein E–Null Mice

  2004cited by this paper
• The year in atherothrombosis.

  2004cited by this paper
• Circulating endothelial progenitor cells, vascular function, and cardiovascular risk.

  2003cited by this paper
• Cholesteryl Ester Transfer Protein: A Novel Target for Raising HDL and Inhibiting Atherosclerosis

  2003cited by this paper
• Intraplaque hemorrhage and progression of coronary atheroma.

  2003cited by this paper
• Molecular motors

  2003cited by this paper
• Importance of different pathways of cellular cholesterol efflux.

  2003cited by this paper
• Endothelial progenitor cells.

  2003cited by this paper
• Long-Term Stable Expression of Human Apolipoprotein A-I Mediated by Helper-Dependent Adenovirus Gene Transfer Inhibits Atherosclerosis Progression and Remodels Atherosclerotic Plaques in a Mouse Model of Familial Hypercholesterolemia

  2003cited by this paper
• Overexpression of Apolipoprotein A-I Promotes Reverse Transport of Cholesterol From Macrophages to Feces In Vivo

  2003cited by this paper
• Genetically Determined Heterogeneity in Hemoglobin Scavenging and Susceptibility to Diabetic Cardiovascular Disease

  2003cited by this paper
• The macrophage hemoglobin scavenger receptor (CD163) as a genetically determined disease modifying pathway in atherosclerosis.

  2002cited by this paper
• Effect of high-density lipoproteins on the expression of adhesion molecules in endothelial cells

  2002cited by this paper
• Synthetic LXR ligand inhibits the development of atherosclerosis in mice

  2002cited by this paper
• Statin Therapy Accelerates Reendothelialization: A Novel Effect Involving Mobilization and Incorporation of Bone Marrow-Derived Endothelial Progenitor Cells

  2002cited by this paper
• Intimomedial Interface Damage and Adventitial Inflammation Is Increased Beneath Disrupted Atherosclerosis in the Aorta: Implications for Plaque Vulnerability

  2002cited by this paper
• Oral Administration of an Apo A-I Mimetic Peptide Synthesized From D-Amino Acids Dramatically Reduces Atherosclerosis in Mice Independent of Plasma Cholesterol

  2002cited by this paper
• Simvastatin Preserves the Structure of Coronary Adventitial Vasa Vasorum in Experimental Hypercholesterolemia Independent of Lipid Lowering

  2002cited by this paper
• CD163: a signal receptor scavenging haptoglobin-hemoglobin complexes from plasma.

  2002influential reference
• High-Dose Recombinant Apolipoprotein A-IMilano Mobilizes Tissue Cholesterol and Rapidly Reduces Plaque Lipid and Macrophage Content in Apolipoprotein E-Deficient Mice: Potential Implications for Acute Plaque Stabilization

  2001cited by this paper
• Coronary artery disease: pathogenesis and acute coronary syndromes.

  2001cited by this paper
• Effects of Lipid-Lowering by Simvastatin on Human Atherosclerotic Lesions: A Longitudinal Study by High-Resolution, Noninvasive Magnetic Resonance Imaging

  2001cited by this paper
• Haptoglobin phenotype and vascular complications in patients with diabetes.

  2000cited by this paper
• Vitamin E supplementation and cardiovascular events in high-risk patients.

  2000cited by this paper
• Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha.

  2000cited by this paper
• Pros and cons of inhibiting cholesteryl ester transfer protein

  2000cited by this paper
• Increased atherosclerosis in ApoE and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression.

  1999cited by this paper

• Extradomain B fibronectin-targeted small interfering RNA-loaded biosynthetic gas vesicles for ultrasound-imaging-guided vulnerable plaque treatment.

  2025cites this paper
• Effectiveness of simvastatin with antibiotics compared to other material on clinical and radiographic outcomes following non-surgical endodontic treatment

  2025cites this paper
• Translational Research of the Acute Effects of Negative Emotions on Vascular Endothelial Health: Findings From a Randomized Controlled Study

  2024cites this paper
• Circulating Endothelial Progenitor and Mesenchymal Stromal Cells as Biomarkers for Monitoring Disease Status and Responses to Exercise

  2022cites this paper
• Inflammatory endothelium-targeted and cathepsin responsive nanoparticles are effective against atherosclerosis

  2022cites this paper
• Macrophage-targeted nanomedicine for chronic diseases immunotherapy

  2021cites this paper
• A Biomicrofluidic Screening Platform for Dysfunctional Endothelium‐Targeted Nanoparticles and Therapeutics

  2021cites this paper
• Gualou-Xiebai-Banxia decoction protects against type II diabetes with acute myocardial ischemia by attenuating oxidative stress and apoptosis via PI3K/Akt/eNOS signaling.

  2021cites this paper
• Proteomic Profiling Reveals the Molecular Changes of Insomnia Patients

  2021cites this paper
• Investigating VCAM-1 Targeted Nanoparticles and Annexin A1 Therapy using Dysfunctional-endothelium-on-a-chip

  2021cites this paper
• Exercise and Cardiovascular Protection.

  2020cites this paper
• Three-Dimensional Imaging of Intraplaque Neovascularization in a Mouse Model of Advanced Atherosclerosis

  2020cites this paper
• Fasting Therapy Contributes to the Improvement of Endothelial Function and Decline in Vascular Injury-Related Markers in Overweight and Obese Individuals via Activating Autophagy of Endothelial Progenitor Cells

  2020cites this paper
• Chapter 15 Endothelial Cell Dysfunction in HIV-1 Infection

  2019cites this paper
• Naringenin Exerts Cardiovascular Protective Effect in a Palmitate-Induced Human Umbilical Vein Endothelial Cell Injury Model via Autophagy Flux Improvement.

  2019cites this paper
• Ischaemic Heart Disease

  2019cites this paper
• Tanshinol borneol ester, a novel synthetic small molecule angiogenesis stimulator inspired by botanical formulations for angina pectoris

  2019cites this paper
• Aerobic exercise inhibits acute lung injury: from mouse to human evidence Exercise reduced lung injury markers in mouse and in cells.

  2018cites this paper
• Neovascularization of Carotid Atherosclerotic Plaque and Quantitative Methods of Its Dynamic Assessment in Vivo

  2018cites this paper
• Microparticles and Exercise in Clinical Populations.

  2018cites this paper
• [Morphometric characteristics of neovascularization of carotid atherosclerotic plaques].

  2018cites this paper
• Endothelial Cell Dysfunction in HIV-1 Infection Endothelial Cell Dysfunction in HIV-1 Infection

  2018cites this paper
• The use of miR-92a inhibitor to enhance endothelial progenitor cell-mediated regeneration of injured arteries

  2018cites this paper
• Endothelial Cell Dysfunction in HIV-1 Infection

  2018cites this paper
• Trichosanthes pericarpium Aqueous Extract Enhances the Mobilization of Endothelial Progenitor Cells and Up-regulates the Expression of VEGF, eNOS, NO, and MMP-9 in Acute Myocardial Ischemic Rats

  2018cites this paper
• Sonodynamic therapy-induced foam cells apoptosis activates the phagocytic PPARγ-LXRα-ABCA1/ABCG1 pathway and promotes cholesterol efflux in advanced plaque

  2018cites this paper
• Berberine-Promoted CXCR4 Expression Accelerates Endothelial Repair Capacity of Early Endothelial Progenitor Cells in Persons with Prehypertension

  2018cites this paper
• Impact of statin therapy intensity on endothelial progenitor cells after percutaneous coronary intervention in diabetic patients. The REMEDY-EPC late study.

  2017cites this paper
• Vascular Health Profile predicts cardiovascular outcomes in patients with diabetes

  2017cites this paper
• BMP4/Id2 signaling pathway is a novel therapeutic target for late outgrowth endothelial progenitor cell-mediated endothelial injury repair.

  2017cites this paper
• Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound

  2017cites this paper
• Is age an important factor for vascular response to statin therapy? A serial optical coherence tomography and intravascular ultrasound study

  2017cites this paper
• Evacetrapib: Another CETP Inhibitor for Dyslipidemia With No Clinical Benefit

  2017cites this paper
• Detection of the Vulnerable Coronary Atherosclerotic Plaque—Promises and Limitations

  2017cites this paper
• Overview of Some Risk Factors in Cardiovascular Disease

  2017cites this paper
• HIV-1 infection, microenvironment and endothelial cell dysfunction.

  2016cites this paper
• Role of Haptoglobin in Health and Disease: A Focus on Diabetes

  2016cites this paper
• Rosuvastatin for Reduction of Myocardial Damage during Coronary Angioplasty - the Remedy Trial

  2016cites this paper
• Hp: an inflammatory indicator in cardiovascular disease.

  2016cites this paper
• THE AGE-RELATED MACULAR DEGENERATION AS A VASCULAR DISEASE: CONTRIBUTIONS TO ITS PATHOGENESIS

  2016cites this paper
• Estudio de la contribución de las células endoteliales progenitoras y las partículas de colesterol HDL en los mecanismos de daño y reparación vascular en pacientes infectados por VIH

  2016influential citation
• Circulating CD14+ and CD14highCD16- classical monocytes are reduced in patients with signs of plaque neovascularization in the carotid artery.

  2016cites this paper
• Cell Therapy and Critical Limb Ischemia: Evidence and Window of Opportunity in Obesity.

  2016cites this paper
• Protective effect of R. glutinosa oligosaccharides against high L-carnitine diet-induced endothelial dysfunction and hepatic injury in mice.

  2016cites this paper
• anemia in st - elev ation my ocardial infar ction Patients with mar kers of inadequate Bone marr ow r esponse

  2015cites this paper
• Anemia in ST-Elevation Myocardial Infarction Patients with Markers of Inadequate Bone Marrow Response.

  2015cites this paper
• L’expression des cyclo-oxygénases et des oxydes nitriques synthases avec les protéines adaptatrices TRAFs dans les cellules progénitrices endothéliales

  2015influential citation
• Microwave-driven synthesis of bisphosphonate nanoparticles allows in vivo visualisation of atherosclerotic plaque

  2015cites this paper
• Exercise mitigates the effects of hyperhomocysteinemia on adverse skeletal muscle remodeling.

  2015cites this paper
• Quantitative analysis of the expression of caspase 3 and caspase 9 in different types of atherosclerotic lesions in the human aorta.

  2015cites this paper
• Organ-specific physiological responses to acute physical exercise and long-term training in humans.

  2014cites this paper
• Exercise mitigates the adverse effects of hyperhomocysteinemia on macrophages, MMP-9, skeletal muscle, and white adipocytes.

  2014cites this paper
• Early cardiac gene transcript levels in peripheral blood mononuclear cells reflect severity in stable coronary artery disease.

  2014cites this paper
• Angiogenesis effect of Astragalus polysaccharide combined with endothelial progenitor cells therapy in diabetic male rat following experimental hind limb ischemia

  2014cites this paper
• Biomaterials for enhancing endothelial progenitor cell (EPC) therapy for cardiac regeneration

  2014cites this paper
• Molecular Imaging of Coronary Atherosclerosis

  2014cites this paper
• Differential regulation of endothelium behavior by progesterone and medroxyprogesterone acetate.

  2014cites this paper
• Rosuvastatin Activates ATP-Binding Cassette Transporter A1–Dependent Efflux Ex Vivo and Promotes Reverse Cholesterol Transport in Macrophage Cells in Mice Fed a High-Fat Diet

  2014cites this paper
• Preparation and characterization of circulating angiogenic cells for tissue engineering applications.

  2014cites this paper
• Exercise Improves Immune Function, Antidepressive Response, and Sleep Quality in Patients with Chronic Primary Insomnia

  2014cites this paper
• THE NEW PERCEPTION THAT AGE-RELATED MACULAR DEGENERATION MAY BE A VASCULAR DISEASE OPENS UP THERAPEUTICAL/PREVENTIVE THERAPEUTCICAL VISTAS FULL OF PROMISE: Part II

  2014cites this paper
• Roles of Chinese medicine bioactive ingredients in the regulation of cellular function of endothelial progenitor cells.

  2014cites this paper
• Nifedipine Enhances Cholesterol Efflux in RAW264.7 Macrophages

  2013cites this paper
• Cholesterol Diet Withdrawal Leads to an Initial Plaque Instability and Subsequent Regression of Accelerated Iliac Artery Atherosclerosis in Rabbits

  2013cites this paper
• Tissue kallikrein is related to the severity of coronary artery disease.

  2013cites this paper
• Evolution and involution of atherosclerosis and its relationship with vascular reactivity in hypercholesterolemic rabbits.

  2013cites this paper
• Exercise is the real polypill.

  2013cites this paper
• Epidemiological Evidence I : Exercise Benefits – How Protective is Exercise per se Against Conventional Cardiovascular Risk Factors Compared With Drugs ?

  2013cites this paper
• Transcriptome Analysis of Genes Regulated by Cholesterol Loading in Two Strains of Mouse Macrophages Associates Lysosome Pathway and ER Stress Response with Atherosclerosis Susceptibility

  2013cites this paper
• Cholesterol--a biological compound as a building block in bionanotechnology.

  2013cites this paper
• Influence of Exercise on Circulating Human Hematopoietic Stem and Progenitor Cells

  2013cites this paper
• Ischemic Heart Disease

  2013cites this paper
• The vulnerable coronary plaque: update on imaging technologies

  2013cites this paper
• Effects of Green Tea Polyphenols under Hyperlipidemic Conditions through their Anti-Angiogenic Activity

  2013cites this paper
• Macrophages Transmit Potent Proangiogenic Effects of oxLDL In Vitro and In Vivo Involving HIF-1α Activation: a Novel Aspect of Angiogenesis in Atherosclerosis

  2013cites this paper
• Plaque neovascularization: defense mechanisms, betrayal, or a war in progress

  2012cites this paper
• The genetic architecture of Secretory PLA2 (sPLA2)genes and their impact on sPLA2 activity/mass and association with CHD risk.

  2012cites this paper
• Endothelial dysfunction in HIV infection--the role of circulating endothelial cells, microparticles, endothelial progenitor cells and macrophages.

  2012cites this paper
• Contemporary Reviews in Cardiovascular Medicine Acute Coronary Events

  2012cites this paper
• Circulating endothelial and progenitor cells: Evidence from acute and long-term exercise effects.

  2012cites this paper
• Endothelial function in patients with newly diagnosed type 2 diabetes receiving early intensive insulin therapy.

  2012cites this paper
• Cardiovascular defense challenges at the basic, clinical, and population levels

  2012cites this paper
• High-Risk Vulnerable Plaques

  2012cites this paper
• Testosterone modulates platelet aggregation and endothelial cell growth through nitric oxide pathway.

  2012cites this paper
• The Pathophysiology of Coronary Artery Disease

  2012cites this paper
• Physical exercise attenuates age‐associated reduction in endothelium‐reparative capacity of endothelial progenitor cells by increasing CXCR4/JAK‐2 signaling in healthy men

  2012cites this paper
• Pathology of plaque haemorrhage and neovascularization of coronary artery.

  2012cites this paper
• Vulnerable Plaque: From Bench to Bedside; Local Pacification Versus Systemic Therapy

  2012cites this paper
• AGE - RELATED MACULAR DEGENERATION IS A VASCULAR DISEASE, PART OF VASCULOPATHY: HOLISTIC APPROACH OF THE AMD'S PATHOPHYSIOLOGY, PREVENTION AND PREVENTIVE TREATMENT

  2012cites this paper
• Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins?

  2012cites this paper
• Atorvastatin accelerates both neointimal coverage and re-endothelialization after sirolimus-eluting stent implantation in a porcine model: new findings from optical coherence tomography and pathology.

  2012cites this paper
• Acute Coronary Events

  2012cites this paper
• HIV-1 and recombinant gp120 affect the survival and differentiation of human vessel wall-derived mesenchymal stem cells

  2011cites this paper
• Can Environmental Factors Predispose Noncommunicable Diseases

  2011cites this paper
• Endothelial progenitor cells: quo vadis?

  2011cites this paper
• Transcriptional fingerprint of human whole blood at the site of coronary occlusion in acute myocardial infarction.

  2011cites this paper
• From Treating Complex Coronary Artery Disease to Promoting Cardiovascular Health: Therapeutic Transitions and Challenges, 2010–2020

  2011cites this paper
• Perspectives and opportunities for nanomedicine in the management of atherosclerosis

  2011cites this paper
• Controlled-Release Basic Fibroblast Growth Factor for Peripheral Artery Disease: Comparison with Autologous Bone Marrow-Derived Stem Cell Transfer

  2011cites this paper
• An integrated approach for the mechanisms responsible for atherosclerotic plaque regression.

  2011cites this paper